-
1
-
-
45849112141
-
Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis
-
Kunos G, Osei-Hyiaman D, (2008) Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis. Am J Physiol Gastrointest Liver Physiol 294: G1101-1104.
-
(2008)
Am J Physiol Gastrointest Liver Physiol
, vol.294
, pp. 1101-1104
-
-
Kunos, G.1
Osei-Hyiaman, D.2
-
2
-
-
38349132542
-
Canabinoid receptors and the regulation of bone mass
-
Bab I, Zimmer A, (2008) Canabinoid receptors and the regulation of bone mass. Br J Pharmacol 153: 182-188.
-
(2008)
Br J Pharmacol
, vol.153
, pp. 182-188
-
-
Bab, I.1
Zimmer, A.2
-
4
-
-
77649275461
-
Cannabinoids and the gut: new developments and emerging concepts
-
Izzo AA, Sharkey KA, (2010) Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 126: 21-38.
-
(2010)
Pharmacol Ther
, vol.126
, pp. 21-38
-
-
Izzo, A.A.1
Sharkey, K.A.2
-
5
-
-
23244457833
-
Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing
-
Wright K, Rooney N, Feeney M, Tate J, Robertson D, et al. (2005) Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology 129: 437-453.
-
(2005)
Gastroenterology
, vol.129
, pp. 437-453
-
-
Wright, K.1
Rooney, N.2
Feeney, M.3
Tate, J.4
Robertson, D.5
-
6
-
-
70149125201
-
Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue
-
Marquéz L, Suárez J, Iglesias M, Bermudez-Silva FJ, Rodríguez de Fonseca F, et al. (2009) Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue. PLoS ONE 4: e6893.
-
(2009)
PLoS ONE
, vol.4
-
-
Marquéz, L.1
Suárez, J.2
Iglesias, M.3
Bermudez-Silva, F.J.4
Rodríguez de Fonseca, F.5
-
7
-
-
11144355734
-
The endogenous cannabinoid system protects against colonic inflammation
-
Massa F, Marsicano G, Hermann H, Cannich A, Monory K, et al. (2004) The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 113: 1202-1209.
-
(2004)
J Clin Invest
, vol.113
, pp. 1202-1209
-
-
Massa, F.1
Marsicano, G.2
Hermann, H.3
Cannich, A.4
Monory, K.5
-
8
-
-
33645832524
-
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation
-
D'Argenio G, Valenti M, Scaglione G, Cosenza V, Sorrentini I, et al. (2006) Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. FASEB J 20: 568-570.
-
(2006)
FASEB J
, vol.20
, pp. 568-570
-
-
D'Argenio, G.1
Valenti, M.2
Scaglione, G.3
Cosenza, V.4
Sorrentini, I.5
-
9
-
-
33745783119
-
Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium
-
Kimball ES, Schneider CR, Wallace NH, Hornby PJ, (2006) Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium. Am J Physiol Gastrointest Liver Physiol 291: G364-371.
-
(2006)
Am J Physiol Gastrointest Liver Physiol
, vol.291
, pp. 364-371
-
-
Kimball, E.S.1
Schneider, C.R.2
Wallace, N.H.3
Hornby, P.J.4
-
10
-
-
48149107173
-
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors
-
Storr M, Keenan C, Emmerdinger D, Zhang H, Yüce B, et al. (2008) Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors. J Mol Med 86: 925-936.
-
(2008)
J Mol Med
, vol.86
, pp. 925-936
-
-
Storr, M.1
Keenan, C.2
Emmerdinger, D.3
Zhang, H.4
Yüce, B.5
-
11
-
-
77954274726
-
Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis
-
Engel MA, Kellermann CA, Burnat G, Hahn EG, Rau T, et al. (2010) Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis. J Physiol Pharmacol 61: 89-97.
-
(2010)
J Physiol Pharmacol
, vol.61
, pp. 89-97
-
-
Engel, M.A.1
Kellermann, C.A.2
Burnat, G.3
Hahn, E.G.4
Rau, T.5
-
12
-
-
77949760982
-
The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease
-
Storr M, Emmerdinger D, Diegelmann J, Pfennig S, Ochsenkühn T, et al. (2010) The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PLoS ONE 5: e9453.
-
(2010)
PLoS ONE
, vol.5
-
-
Storr, M.1
Emmerdinger, D.2
Diegelmann, J.3
Pfennig, S.4
Ochsenkühn, T.5
-
13
-
-
38149055682
-
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
-
Izzo A, Aviello G, Petrosino S, Orlando P, Marsicano G, et al. (2008) Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. J Mol Med 86: 89-98.
-
(2008)
J Mol Med
, vol.86
, pp. 89-98
-
-
Izzo, A.1
Aviello, G.2
Petrosino, S.3
Orlando, P.4
Marsicano, G.5
-
14
-
-
67650088001
-
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon
-
Santoro A, Pisanti S, Grimaldi C, Izzo AA, Borrelli F, et al. (2009) Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon. Int J Cancer 125: 996-1003.
-
(2009)
Int J Cancer
, vol.125
, pp. 996-1003
-
-
Santoro, A.1
Pisanti, S.2
Grimaldi, C.3
Izzo, A.A.4
Borrelli, F.5
-
15
-
-
76749083341
-
Antitumorigenic effects of cannabinoids beyond apoptosis
-
Freimuth N, Ramer R, Hinz B, (2010) Antitumorigenic effects of cannabinoids beyond apoptosis. J Pharmacol Exp Ther 332: 336-344.
-
(2010)
J Pharmacol Exp Ther
, vol.332
, pp. 336-344
-
-
Freimuth, N.1
Ramer, R.2
Hinz, B.3
-
16
-
-
77954378342
-
Targeting the endocannabinoid system for the treatment of cancer - a practical view
-
Fowler CJ, Gustafsson SB, Chung SC, Persson E, Jacobsson SO, et al. (2010) Targeting the endocannabinoid system for the treatment of cancer- a practical view. Curr Top Med Chem 10: 814-827.
-
(2010)
Curr Top Med Chem
, vol.10
, pp. 814-827
-
-
Fowler, C.J.1
Gustafsson, S.B.2
Chung, S.C.3
Persson, E.4
Jacobsson, S.O.5
-
17
-
-
0042972716
-
Possible endocannabinoid control of colorectal cancer growth
-
Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio M, et al. (2003) Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125: 677-687.
-
(2003)
Gastroenterology
, vol.125
, pp. 677-687
-
-
Ligresti, A.1
Bisogno, T.2
Matias, I.3
de Petrocellis, L.4
Cascio, M.5
-
18
-
-
59449111015
-
Cannabinoid receptor activation induces apoptosis through tumor necrosis factor α-mediated ceramide de novo synthesis in colon cancer cells
-
Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, et al. (2008) Cannabinoid receptor activation induces apoptosis through tumor necrosis factor α-mediated ceramide de novo synthesis in colon cancer cells. Clin Cancer Res 14: 7691-7700.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 7691-7700
-
-
Cianchi, F.1
Papucci, L.2
Schiavone, N.3
Lulli, M.4
Magnelli, L.5
-
19
-
-
58849113520
-
Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil
-
Gustafsson SB, Lindgren T, Jonsson M, Jacobsson SOP, (2009) Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil. Cancer Chemother Pharmacol 63: 691-701.
-
(2009)
Cancer Chemother Pharmacol
, vol.63
, pp. 691-701
-
-
Gustafsson, S.B.1
Lindgren, T.2
Jonsson, M.3
Jacobsson, S.O.P.4
-
20
-
-
77955807756
-
Effects of anandamide on polyamine levels and cell growth in human colon cancer cells
-
Linsalata M, Notarnicola M, Tutino V, Bifulco M, Santoro A, et al. (2010) Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. Anticancer Res 30: 2583-2589.
-
(2010)
Anticancer Res
, vol.30
, pp. 2583-2589
-
-
Linsalata, M.1
Notarnicola, M.2
Tutino, V.3
Bifulco, M.4
Santoro, A.5
-
21
-
-
51049102995
-
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth
-
Wang D, Wang H, Ning W, Backlund M, Dey S, et al. (2008) Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res 68: 6468-6476.
-
(2008)
Cancer Res
, vol.68
, pp. 6468-6476
-
-
Wang, D.1
Wang, H.2
Ning, W.3
Backlund, M.4
Dey, S.5
-
22
-
-
65449125869
-
Single nucleotide change in the cannabinoid receptor-1 (CNR1) gene in colorectal cancer outcome
-
Bedoya F, Rubio J, Morales-Gutierrez C, Abad-Barahona A, Lora Pablos D, et al. (2009) Single nucleotide change in the cannabinoid receptor-1 (CNR1) gene in colorectal cancer outcome. Oncology 76: 435-441.
-
(2009)
Oncology
, vol.76
, pp. 435-441
-
-
Bedoya, F.1
Rubio, J.2
Morales-Gutierrez, C.3
Abad-Barahona, A.4
Lora Pablos, D.5
-
23
-
-
36649005377
-
Molecular heterogeneity of colorectal cancer: Implications for cancer control
-
Jass JR, (2007) Molecular heterogeneity of colorectal cancer: Implications for cancer control. Surg Oncol 16 (Suppl 1): S7-9.
-
(2007)
Surg Oncol
, vol.16
, Issue.SUPPL. 1
, pp. 7-9
-
-
Jass, J.R.1
-
24
-
-
33947432482
-
High macrophage infiltration along the tumor front correlates with improved survival in colon cancer
-
Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, et al. (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13: 1472-1479.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 1472-1479
-
-
Forssell, J.1
Oberg, A.2
Henriksson, M.L.3
Stenling, R.4
Jung, A.5
-
25
-
-
77949759545
-
The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status
-
Dahlin AM, Palmqvist R, Henriksson ML, Jacobsson M, Eklöf V, et al. (2010) The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin Cancer Res 16: 1845-1855.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1845-1855
-
-
Dahlin, A.M.1
Palmqvist, R.2
Henriksson, M.L.3
Jacobsson, M.4
Eklöf, V.5
-
26
-
-
22144465217
-
A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci
-
Shinto E, Mochizuki H, Ueno H, Matsubara O, Jass JR, (2005) A novel classification of tumour budding in colorectal cancer based on the presence of cytoplasmic pseudo-fragments around budding foci. Histopathology 47: 25-31.
-
(2005)
Histopathology
, vol.47
, pp. 25-31
-
-
Shinto, E.1
Mochizuki, H.2
Ueno, H.3
Matsubara, O.4
Jass, J.R.5
-
27
-
-
57649242673
-
A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
-
Chung SC, Hammarsten P, Josefsson A, Stattin P, Granfors T, et al. (2009) A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer. Eur J Cancer 45: 174-82.
-
(2009)
Eur J Cancer
, vol.45
, pp. 174-182
-
-
Chung, S.C.1
Hammarsten, P.2
Josefsson, A.3
Stattin, P.4
Granfors, T.5
-
28
-
-
55249083610
-
Specificity of immunoreactions: the importance of testing specificity in each method
-
Lorincz A, Nusser Z, (2008) Specificity of immunoreactions: the importance of testing specificity in each method. J Neurosci 28: 9083-9086.
-
(2008)
J Neurosci
, vol.28
, pp. 9083-9086
-
-
Lorincz, A.1
Nusser, Z.2
-
29
-
-
84857234521
-
The use of knockout mice to test the specificity of antibodies for cannabinoid receptors
-
Hippocampus, in press (published online 2 May 2011; DOI: 10.1002/hipo.20946)
-
Ashton JC, (2011) The use of knockout mice to test the specificity of antibodies for cannabinoid receptors. Hippocampus, in press (published online 2 May 2011; DOI: 10.1002/hipo.20946).
-
(2011)
-
-
Ashton, J.C.1
-
30
-
-
0034003099
-
Specificity controls for immunocytochemical methods
-
Burry RW, (2000) Specificity controls for immunocytochemical methods. J Histochem Cytochem 48: 163-165.
-
(2000)
J Histochem Cytochem
, vol.48
, pp. 163-165
-
-
Burry, R.W.1
-
31
-
-
33845599552
-
Tumour budding in colorectal carcinoma
-
Prall F, (2007) Tumour budding in colorectal carcinoma. Histopathology 50: 151-162.
-
(2007)
Histopathology
, vol.50
, pp. 151-162
-
-
Prall, F.1
-
32
-
-
0033587747
-
CpG island methylator phenotype in colorectal cancer
-
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96: 8681-8686.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 8681-8686
-
-
Toyota, M.1
Ahuja, N.2
Ohe-Toyota, M.3
Herman, J.G.4
Baylin, S.B.5
-
33
-
-
11344286311
-
The staging of colorectal cancer: 2004 and beyond
-
Compton CC, Greene FL, (2004) The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 54: 295-308.
-
(2004)
CA Cancer J Clin
, vol.54
, pp. 295-308
-
-
Compton, C.C.1
Greene, F.L.2
-
34
-
-
0031932041
-
CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells
-
McIntosh HH, Song C, Howlett AC, (1998) CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells. Brain Res Mol Brain Res 53: 163-173.
-
(1998)
Brain Res Mol Brain Res
, vol.53
, pp. 163-173
-
-
McIntosh, H.H.1
Song, C.2
Howlett, A.C.3
-
35
-
-
46749113793
-
Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3
-
Rozenfeld R, Devi LA, (2008) Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J 22: 2311-2322.
-
(2008)
FASEB J
, vol.22
, pp. 2311-2322
-
-
Rozenfeld, R.1
Devi, L.A.2
-
36
-
-
58149089606
-
CB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancy
-
Horne AW, Phillips JA 3rd, Kane N, Lourenco PC, McDonald SE, et al. (2008) CB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancy. PLoS ONE 3: e3969.
-
(2008)
PLoS ONE
, vol.3
-
-
Horne, A.W.1
Phillips 3rd, J.A.2
Kane, N.3
Lourenco, P.C.4
McDonald, S.E.5
-
37
-
-
73649118803
-
Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors
-
Scavone JL, Mackie K, Van Bockstaele EJ, (2010) Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors. Brain Res 1312: 18-31.
-
(2010)
Brain Res
, vol.1312
, pp. 18-31
-
-
Scavone, J.L.1
Mackie, K.2
van Bockstaele, E.J.3
-
38
-
-
0032771955
-
Internalization and recycling of the CB1 cannabinoid receptor
-
Hsieh C, Brown S, Derleth C, Mackie K, (1999) Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem 73: 493-501.
-
(1999)
J Neurochem
, vol.73
, pp. 493-501
-
-
Hsieh, C.1
Brown, S.2
Derleth, C.3
Mackie, K.4
-
39
-
-
77955653663
-
Cannabinoid Receptor 1 trafficking and the role of the intracellular pool: implications for therapeutics
-
Grimsey NL, Graham ES, Dragunow M, Glass M, (2010) Cannabinoid Receptor 1 trafficking and the role of the intracellular pool: implications for therapeutics. Biochem Pharmacol 80: 1050-1062.
-
(2010)
Biochem Pharmacol
, vol.80
, pp. 1050-1062
-
-
Grimsey, N.L.1
Graham, E.S.2
Dragunow, M.3
Glass, M.4
-
40
-
-
0142166330
-
Cannabinoids: potential anticancer agents
-
Guzmán M, (2003) Cannabinoids: potential anticancer agents. Nature Rev Cancer 3: 745-755.
-
(2003)
Nature Rev Cancer
, vol.3
, pp. 745-755
-
-
Guzmán, M.1
-
41
-
-
75449108186
-
Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors
-
Zlobec I, Lugli A, (2009) Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 15: 5898-5906.
-
(2009)
World J Gastroenterol
, vol.15
, pp. 5898-5906
-
-
Zlobec, I.1
Lugli, A.2
-
42
-
-
33845863911
-
Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids
-
Börner C, Höllt V, Sebald W, Kraus J, (2007) Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids. J Leukoc Biol 81: 336-343.
-
(2007)
J Leukoc Biol
, vol.81
, pp. 336-343
-
-
Börner, C.1
Höllt, V.2
Sebald, W.3
Kraus, J.4
-
43
-
-
40949107635
-
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4
-
Todaro M, Lombardo Y, Francipane MG, Alea MP, Cammareri P, et al. (2008) Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ 15: 762-772.
-
(2008)
Cell Death Differ
, vol.15
, pp. 762-772
-
-
Todaro, M.1
Lombardo, Y.2
Francipane, M.G.3
Alea, M.P.4
Cammareri, P.5
-
44
-
-
77953943322
-
Epithelial interleukin-4 receptor expression promotes colon tumor growth
-
Koller FL, Hwang DG, Dozier EA, Fingleton B, (2010) Epithelial interleukin-4 receptor expression promotes colon tumor growth. Carcinogenesis 31: 1010-1017.
-
(2010)
Carcinogenesis
, vol.31
, pp. 1010-1017
-
-
Koller, F.L.1
Hwang, D.G.2
Dozier, E.A.3
Fingleton, B.4
-
45
-
-
58149331057
-
DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers
-
Jorissen RN, Lipton L, Gibbs P, Chapman M, Desai J, et al. (2008) DNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers. Clin Cancer Res 14: 8061-8069.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 8061-8069
-
-
Jorissen, R.N.1
Lipton, L.2
Gibbs, P.3
Chapman, M.4
Desai, J.5
-
46
-
-
36448980876
-
Chemotherapeutic implications in microsatellite unstable colorectal cancer
-
Jo W-S, Carethers JM, (2006) Chemotherapeutic implications in microsatellite unstable colorectal cancer. Cancer Biomark 2: 51-60.
-
(2006)
Cancer Biomark
, vol.2
, pp. 51-60
-
-
Jo, W.-S.1
Carethers, J.M.2
-
47
-
-
33750298256
-
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
-
Xu X, Liu Y, Huang S, Liu G, Xie C, et al. (2006) Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Gen Cytogen 171: 31-38.
-
(2006)
Cancer Gen Cytogen
, vol.171
, pp. 31-38
-
-
Xu, X.1
Liu, Y.2
Huang, S.3
Liu, G.4
Xie, C.5
-
48
-
-
38349060681
-
Cannabinoids in pancreatic cancer: correlation with survival and pain
-
Michalski C, Oti F, Erkan M, Sauliunaite D, Bergmann F, et al. (2008) Cannabinoids in pancreatic cancer: correlation with survival and pain. Int J Cancer 122: 742-750.
-
(2008)
Int J Cancer
, vol.122
, pp. 742-750
-
-
Michalski, C.1
Oti, F.2
Erkan, M.3
Sauliunaite, D.4
Bergmann, F.5
-
49
-
-
77952532122
-
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas
-
Cudaback E, Marrs W, Moeller T, Stella N, (2010) The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. PLoS ONE 5: e8702.
-
(2010)
PLoS ONE
, vol.5
-
-
Cudaback, E.1
Marrs, W.2
Moeller, T.3
Stella, N.4
-
50
-
-
78650812262
-
Tumour cannabinoid CB1 receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer
-
Fowler CJ, Hammarsten P, Bergh A, (2010) Tumour cannabinoid CB1 receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer. PLoS ONE 5: e15205.
-
(2010)
PLoS ONE
, vol.5
-
-
Fowler, C.J.1
Hammarsten, P.2
Bergh, A.3
-
51
-
-
77953624228
-
Stage II and stage III colon cancer: treatment advances and future directions
-
Rousseau B, Chibaudel B, Bachet JB, Larsen AK, Tournigand C, et al. (2010) Stage II and stage III colon cancer: treatment advances and future directions. Cancer J 16: 202-209.
-
(2010)
Cancer J
, vol.16
, pp. 202-209
-
-
Rousseau, B.1
Chibaudel, B.2
Bachet, J.B.3
Larsen, A.K.4
Tournigand, C.5
|